Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular Disease
Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.
